NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 20 04:00PM ET
302.01
Dollar change
-5.19
Percentage change
-1.69
%
IndexDJIA, S&P 500 P/E12.62 EPS (ttm)23.92 Insider Own0.22% Shs Outstand910.00M Perf Week-5.18%
Market Cap273.97B Forward P/E11.80 EPS next Y25.60 Insider Trans5.82% Shs Float905.11M Perf Month-6.09%
Enterprise Value- PEG5.71 EPS next Q4.97 Inst Own91.30% Short Float1.20% Perf Quarter-40.93%
Income22.11B P/S0.67 EPS this Y-19.87% Inst Trans0.31% Short Ratio0.68 Perf Half Y-39.42%
Sales410.06B P/B2.89 EPS next Y15.50% ROA7.44% Short Interest10.84M Perf YTD-40.30%
Book/sh104.44 P/C- EPS next 5Y2.21% ROE24.33% 52W Range248.88 - 630.73 Perf Year-38.27%
Cash/sh- P/FCF11.02 EPS past 3/5Y-4.99% 1.60% ROIC13.29% 52W High-52.12% Perf 3Y-34.59%
Dividend Est.8.63 (2.86%) EV/EBITDA- Sales past 3/5Y11.65% 10.57% Gross Margin- 52W Low21.35% Perf 5Y5.49%
Dividend TTM8.51 (2.82%) EV/Sales- EPS Y/Y TTM45.24% Oper. Margin8.16% Volatility1.07% 1.43% Perf 10Y156.70%
Dividend Ex-DateJun 16, 2025 Quick Ratio- Sales Y/Y TTM8.68% Profit Margin5.39% RSI (14)36.58 Recom1.86
Dividend Gr. 3/5Y13.46% 14.59% Current Ratio0.85 EPS Q/Q548.50% SMA20-0.43% Beta0.45 Target Price364.32
Payout52.75% Debt/Eq0.86 Sales Q/Q9.80% SMA50-19.14% Rel Volume1.00 Prev Close307.20
Employees400000 LT Debt/Eq0.75 EarningsApr 17 BMO SMA200-39.97% Avg Volume16.02M Price302.01
IPOOct 17, 1984 Option/ShortYes / Yes EPS/Sales Surpr.-1.26% -1.80% Trades Volume15,950,754 Change-1.69%
Date Action Analyst Rating Change Price Target Change
Jun-11-25Downgrade Robert W. Baird Outperform → Neutral $312
May-21-25Downgrade HSBC Securities Hold → Reduce $270
May-19-25Downgrade TD Cowen Buy → Hold $308
May-14-25Downgrade Raymond James Strong Buy → Mkt Perform
May-14-25Downgrade BofA Securities Buy → Neutral $350
Apr-22-25Downgrade HSBC Securities Buy → Hold $490
Apr-21-25Downgrade Argus Buy → Hold
Jan-10-25Upgrade HSBC Securities Hold → Buy $595
Jan-06-25Reiterated Truist Buy $625 → $610
Oct-17-24Downgrade HSBC Securities Buy → Hold
Jun-20-25 05:50PM
08:18AM
08:13AM
06:59AM
03:03AM
07:00AM Loading…
Jun-19-25 07:00AM
Jun-18-25 09:36AM
06:20AM
06:20AM
05:30AM
03:55AM
Jun-17-25 09:00PM
03:13PM
02:27PM
02:15PM
02:11PM Loading…
02:11PM
02:06PM
01:27PM
11:18AM
11:15AM
09:33AM
02:23AM
12:22AM
Jun-16-25 06:38PM
12:19PM
11:40AM
Jun-15-25 09:59AM
05:46AM
05:33AM
Jun-14-25 08:02AM
02:24PM Loading…
Jun-13-25 02:24PM
10:09AM
09:00AM
Jun-12-25 02:32PM
08:01AM
04:46AM
Jun-11-25 05:45PM
05:23PM
11:39AM
06:20AM
06:20AM
04:17AM
Jun-10-25 07:11PM
10:13AM
09:52AM
12:02AM
Jun-09-25 01:55PM
01:42PM
09:30AM
06:55AM
06:13AM
06:00AM
Jun-08-25 12:00PM
09:05AM
05:41AM
05:40AM
Jun-07-25 10:05AM
09:47AM
07:30AM
05:23AM
Jun-06-25 04:08PM
08:20AM
Jun-05-25 01:53PM
09:22AM
06:23AM
03:48AM
Jun-04-25 05:45PM
02:00PM
06:50AM
Jun-03-25 05:19PM
10:28AM
06:20AM
Jun-02-25 04:15PM
12:40PM
12:15PM
11:50AM
11:14AM
09:46AM
09:03AM
06:57AM
06:00AM
Jun-01-25 05:32PM
May-31-25 07:00AM
May-30-25 05:28PM
03:29PM
06:00AM
05:49AM
04:50AM
01:35AM
May-29-25 11:36PM
05:45PM
02:13PM
09:17AM
07:10AM
May-28-25 03:01PM
01:01PM
12:13PM
12:13PM
12:06PM
09:11AM
UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Conway Patrick HughChief Executive Officer, OptumJun 10 '25Sale305.00589179,64510,398Jun 12 05:13 PM
Conway Patrick HughOfficerJun 10 '25Proposed Sale305.00589179,645Jun 10 10:33 AM
REX JOHN FPresident & CFOMay 16 '25Buy291.1217,1754,999,919203,796May 16 06:11 PM
HEMSLEY STEPHEN JCEO, UHGMay 16 '25Buy288.5786,70025,019,019679,493May 16 06:11 PM
FLYNN TIMOTHY PATRICKDirectorMay 14 '25Buy320.801,533491,7866,033May 16 12:28 PM
Gil KristenDirectorMay 15 '25Buy271.173,7001,003,3293,818May 16 12:23 PM
Noseworthy John HDirectorMay 14 '25Buy312.1630093,6476,063May 16 12:22 PM
REX JOHN FPresident & CFOFeb 07 '25Option Exercise108.9725,5042,779,171191,691Feb 07 04:06 PM
FLYNN TIMOTHY PATRICKDirectorJan 17 '25Buy511.571,000511,5754,500Jan 22 04:05 PM
McSweeney ErinEVP & Chief People OfficerNov 11 '24Sale626.23701438,9877,105Nov 13 04:35 PM
McSweeney ErinOfficerNov 11 '24Proposed Sale626.23701438,987Nov 12 11:32 AM
ROOS THOMAS EChief Accounting OfficerJul 17 '24Sale569.882,8511,624,73429,501Jul 19 04:26 PM
McSweeney ErinEVP & Chief People OfficerJul 18 '24Sale579.031,500868,5387,785Jul 19 04:26 PM